
Cardiovascular Diseases
Learn about the latest trends, discover events and innovations in the changing world of cardiovascular disease.
Science in Cardiovascular Diseases
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

- Atherothrombosis
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

- Dyslipidemia
- Cardiovascular
Single-Pill Combinations in Dyslipidemia
This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).

- Dyslipidemia
- Cardiovascular
Should we encourage earlier and broader use of combination therapies in dyslipidemia?

- Dyslipidemia
- Cardiovascular
Prescription Trends of Oral Non-Statin LLTs and Their Effects on LDL-C
Prescription Trends of Oral Non-Statin Lipid‑Lowering Therapies and Their Effects on Low-Density Lipoprotein-Cholesterol

- Thrombosis
Changing trends in VTE: Pulmonary Embolism cases on Rise within the Last Decade
Danish study finds more elderly and patients with comorbidities being diagnosed.
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources

- Dyslipidemia
- Cardiovascular
Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

- Dyslipidemia
- Cardiovascular
Switching From Statin Monotherapy to Statin/Ezetimibe Combination
-from-the-SAFEHEART-registry-(1).webp/jcr:content/Clinical%20practice%20experience%20in%20patients%20with%20familial%20hypercholesterolemia%20(FH)%20from%20the%20SAFEHEART%20registry%20(1).webp)
- Dyslipidemia
- Cardiovascular
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the Safeheart registry

- Cardiovascular
- Atherothrombosis
- Atherothrombosis
No Rebound Effect Post Clopidogrel Withdrawal
Events
Stay up to date and register for the latest events and view webinar recordings.

- Dyslipidemia
VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond
Prof. Joseph A. Caprini provides insights on VTE Risk in Hospital and beyond by supporting the initiative on preventing the number one preventable cause of death after surgery: fetal pulmonary embolism
.jpg/jcr:content/image%20(5).jpg)